TrialBlood cancer journal2021

Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

Sanjal H Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.